Key result
Leadless pacemakers reduce infection and lead complications versus transvenous pacemakers after valve replacement.
Why the study?
The advantages of leadless pacemakers over traditional transvenous pacemakers in reducing infections and lead complications are particularly important after transcutaneous valve replacement or valve surgery.
Do leadless pacemakers reduce complications compared to traditional transvenous permanent pacemakers in patients after transcutaneous and surgical valve replacements?
Do leadless pacemakers reduce complications compared to traditional transvenous permanent pacemakers in patients after transcutaneous and surgical valve replacements?
Leadless pacemakers offer a safer alternative to traditional pacemakers by reducing infection and lead-related complications, which is especially beneficial for patients undergoing valve replacement.
Leadless pacemakers' (LPs) main advantage over the traditional transvenous permanent pacemakers (TV-PPMs) is the absence of leads and subcutaneous pocket. These intracardiac pacemakers have been shown in observational studies to reduce long-term complications as compared with TV-PPM mainly by reducing the need for re-intervention. Two major advantages of this technology are the lower rate of infection (absence of pocket and lower rate of bacterial seeding) and lead-related complications (dislodgment). Hence, these advantages are more accentuated after transcutaneous valve replacement or valve surgery and clinical situations where it is important to reduce systemic infections and endocarditis. In this review, we highlight the role of LP in patients after transcutaneous and surgical valve replacements.
No takes yet. Share an insight, caveat, or question.
El‐Chami et al. (2025) conducted a review in Patients after transcutaneous and surgical valve replacements requiring pacing. Leadless pacemakers (LPs) vs. Traditional transvenous permanent pacemakers (TV-PPMs) was evaluated. Leadless pacemakers offer advantages over traditional transvenous pacemakers by reducing infection and lead-related complications, particularly in patients after transcutaneous and surgical valve replacements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: